Table 3. Multivariate analysis of factors associated with pCR.
| Parameters | OR | 95% CI | P value |
|---|---|---|---|
| AJCC stage | 0.690 | 0.316–1.505 | 0.351 |
| Clinical tumor size | 1.291 | 0.593–2.812 | 0.520 |
| Clinical lymph node status | 0.981 | 0.298–3.233 | 0.975 |
| Targeted therapy cycles | 0.911 | 0.237–3.507 | 0.893 |
| Neoadjuvant cycles | 0.575 | 0.246–1.343 | 0.201 |
| Anthracycline or non-anthracycline | 0.593 | 0.133–2.642 | 0.493 |
| HR status | 0.444 | 0.235–0.839 | 0.012 |
| Taxanes | 2.099 | 0.951–4.632 | 0.066 |
| Ki-67 | 0.349 | 0.130–0.933 | 0.036 |
pCR, pathological complete response; OR, odds ratio; CI, confidence interval; AJCC, American Joint Committee on Cancer; HR, hormone receptor.